Protein Summary
Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential). Forms a filamentous structure with SEPT12, SEPT6, SEPT2 and probably SEPT4 at the sperm annulus which is required for the structural integrity and motility of the sperm tail during postmeiotic differentiation (PubMed:25588830). May play a role in platelet secretion. Isoform ARTS, but not the other isoforms, is required for the induction of cell death mediated by TGF-beta and by other apoptotic stimuli. This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been ...more
- ENST00000317256
- ENSP00000321071
- ENSG00000108387
- ENST00000317268
- ENSP00000321674
- ENST00000393086
- ENSP00000376801
- ENST00000412945
- ENSP00000414779
- ENST00000426861
- ENSP00000402348
- ENST00000457347
- ENSP00000402000
- ENST00000583114
- ENSP00000463768
- ARTS
- PNUTL2
- SEP4
- H5
- ARTS
- MART
- SEP4
- CE5B3
- PNUTL2
- hucep-7
- BRADEION
- C17orf47
- hCDCREL-2
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
molecular function | 0.93 | ||
transcription factor perturbation | 0.74 | ||
cellular component | 0.71 | ||
disease perturbation | 0.68 | ||
kinase perturbation | 0.66 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 339.88 (req: < 5)
Gene RIFs: 35 (req: <= 3)
Antibodies: 242 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 339.88 (req: >= 5)
Gene RIFs: 35 (req: > 3)
Antibodies: 242 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 19
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0